Registration obtained for Aivial™ in Moldova

Aicore Life Science, Netherlands, obtained marketing authorization in Moldova for Aivial™ in November 2021. Market introductions are expected in the second half of 2023.

About Aivial™

Aivial™ is a synthetic steroid (tibolone) intended to be used for hormone replacement therapy. Aivial is a bioequivalent of Livial® 2.5mg which is a product that mimics the activity of the female sex hormones in the body, and is used especially for the relief of symptoms occurring after menopause. In some countries, this product is also used for the prevention of osteoporosis. It has been demonstrated that tibolone has favourable effects on various tissues in the body, such as brain, vagina and bone.